FoxO1: A molecule for all seasons

Journal of Bone and Mineral Research

Volumn 26, Issue 5, 2011, Pages 912-917

  Kousteni, Stavroula ^a,b  

^a Columbia University ^*  (United States)

^b Russ Berrie Medical Sciences Pavilion   (United States)

Author keywords

ENERGY HOMEOSTASIS; GLUCOSE; INSULIN; OSTEOBLASTS; OXIDATIVE STRESS; PROLIFERATION; PROTEIN SYNTHESIS

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; OSTEOCALCIN; TRANSCRIPTION FACTOR FOXO;

ADIPOCYTE; AGING; ANGIOGENESIS; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOCRINE FUNCTION; GLUCOSE METABOLISM; HEMATOPOIESIS; INSULIN SENSITIVITY; LIVER CELL; MYOBLAST; OSTEOBLAST; PANCREAS ISLET BETA CELL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETON; STRESS; THYMOCYTE;

ANIMALS; BONE AND BONES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS;

EID: 79955594241     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.306     Document Type: Article

References (52)

1. Accili D, Arden KC., FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004; 117: 421-426. (Pubitemid 38610228)
2. Greer EL, Brunet A., FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene. 2005; 24: 7410-7425. (Pubitemid 41637981)
3. Arden KC., Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer. Exp Gerontol. 2006; 41: 709-717.
4. Murakami S., Stress resistance in long-lived mouse models. Exp Gerontol. 2006; 41: 1014-1019. (Pubitemid 44821697)
5. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007; 128: 325-339. (Pubitemid 46137992)
6. Nakae J, Park BC, Accili D., Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem. 1999; 274: 15982-15985.
7. Essers MA, Weijzen S, de Vries-Smits AM, et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004; 23: 4802-4812. (Pubitemid 40069710)
8. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004; 303: 2011-2015. (Pubitemid 38393275)
9. Huang H, Regan KM, Wang F, et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc Natl Acad Sci. 2005; 102: 1649-1654. (Pubitemid 40209222)
10. Lehtinen MK, Yuan Z, Boag PR, et al. A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell. 2006; 125: 987-1001. (Pubitemid 43795191)
11. Oh SW, Mukhopadhyay A, Svrzikapa N, Jiang F, Davis RJ, Tissenbaum HA., JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc Natl Acad Sci. 2005; 102: 4494-4499. (Pubitemid 40397140)
12. Finkel T, Holbrook NJ., Oxidants, oxidative stress, and the biology of ageing. Nature. 2000; 408: 239-247.
13. Quarrie JK, Riabowol KT., Murine models of life span extension. Sci Aging Knowledge Environ. 2004; 2004: re5.
14. Levasseur R, Barrios R, Elefteriou F, Glass DA, Lieberman MW, Karsenty G., Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. Endocrinology. 2003; 144: 2761-2764. (Pubitemid 36819873)
15. Bai XC, Lu D, Bai J, et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem Biophys Res Commun. 2004; 314: 197-207. (Pubitemid 38058389)
16. Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 2003; 112: 915-923. (Pubitemid 38063749)
17. Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282: 27285-27297. (Pubitemid 47501960)
18. Liu JW, Chandra D, Rudd MD, et al. Induction of prosurvival molecules by apoptotic stimuli: involvement of FOXO3a and ROS. Oncogene. 2005; 24: 2020-2031. (Pubitemid 40516195)
19. Nemoto S, Finkel T., Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002; 295: 2450-2452. (Pubitemid 34270258)
20. Rached MT, Kode A, Xu L, et al. FoxO1 is a positive regulator of bone formation by favoring protein synthesis and resistance to oxidative stress in osteoblasts. Cell Metab. 2010; 11: 147-160.
21. Ambrogini E, Almeida M, Martin-Millan M, et al. FoxO-mediated defense against oxidative stress in osteoblasts is indispensable for skeletal homeostasis in mice. Cell Metab. 2010; 11: 136-146.
22. Glass DA, Bialek P, Ahn JD, et al. Canonical wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell. 2005; 8: 751-764. (Pubitemid 40585297)
23. Almeida M, Han L, Martin-Millan M, O'Brien CA, Manolagas SC., Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting beta-catenin from T cell factor- to forkhead box O-mediated transcription. J Biol Chem. 2007; 282: 27298-27305. (Pubitemid 47501978)
24. Nakamura H, Nakamura K, Yodoi J., Redox regulation of cellular activation. Annu Rev Immunol. 1997; 15: 351-369. (Pubitemid 27169285)
25. Nogueira V, Park Y, Chen CC, et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell. 2008; 14: 458-470.
26. Satyanarayana A, Rudolph KL., p16 and ARF: activation of teenage proteins in old age. J Clin Invest. 2004; 114: 1237-1240. (Pubitemid 40385293)
27. Rached MT, Kode A, Silva BC, et al. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest. 2010; 120: 357-368.
28. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130: 456-469. (Pubitemid 47208519)
29. Ferron M, Wei J, Yoshizawa T, et al. Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism. Cell. 2010; 142: 296-308.
30. Fulzele K, Riddle RC, Digirolamo DJ, et al. Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition. Cell. 2010; 142: 309-319.
31. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B., Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009; 94: 827-832.
32. Kindblom JM, Ohlsson C, Ljunggren O, et al. Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men. J Bone Miner Res. 2009; 24: 785-791.
33. Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009; 94: 45-49.
34. Saleem U, Mosley TH Jr, Kullo IJ., Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2010; 30: 1474-1478.
35. Nakae J, Biggs WH III, Kitamura T, et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet. 2002; 32: 245-253.
36. Matsumoto M, Pocai A, Rossetti L, DePinho RA, Accili D., Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metab. 2007; 6: 208-216. (Pubitemid 47336849)
37. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 2003; 423: 550-555. (Pubitemid 36648580)
38. Nakae J, Kitamura T, Kitamura Y, Biggs WH III, Arden KC, Accili D., The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 2003; 4: 119-129. (Pubitemid 36105338)
39. Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D., Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J Cell Biol. 2003; 162: 535-541. (Pubitemid 37022932)
40. Kitamura YI, Kitamura T, Kruse JP, et al. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab. 2005; 2: 153-163.
41. Kitamura T, Nakae J, Kitamura Y, et al. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest. 2002; 110: 1839-1847. (Pubitemid 36076491)
42. Hashimoto N, Kido Y, Uchida T, et al. Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass. Nat Genet. 2006; 38: 589-593.
43. Kitamura T, Feng Y, Kitamura YI, et al. Forkhead protein FoxO1 mediates Agrp-dependent effects of leptin on food intake. Nat Med. 2006; 12: 534-540.
44. Yang G, Lim CY, Li C, et al. FoxO1 inhibits leptin regulation of pro-opiomelanocortin promoter activity by blocking STAT3 interaction with specificity protein 1. J Biol Chem. 2009; 284: 3719-3727.
45. Calabrese EJ., Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment. Toxicol Appl Pharmacol. 2004; 197: 125-136. (Pubitemid 38639903)
46. Mattson MP, Duan W, Chan SL, et al. Neuroprotective and neurorestorative signal transduction mechanisms in brain aging: modification by genes, diet and behavior. Neurobiol Aging. 2002; 23: 695-705. (Pubitemid 35217696)
47. Sinclair DA., Yeast aging research: recent advances and medical relevance. Cell Mol Life Sci. 1999; 56: 807-816.
48. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Sinclair DA., Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature. 2003; 423: 181-185. (Pubitemid 36569542)
49. Turturro A, Hass BS, Hart RW., Does caloric restriction induce hormesis ? Hum Exp Toxicol. 2000; 19: 320-329.
50. Jiang JC, Jaruga E, Repnevskaya MV, Jazwinski SM., An intervention resembling caloric restriction prolongs life span and retards aging in yeast. FASEB J. 2000; 14: 2135-2137.
51. Lin SJ, Defossez PA, Guarente L., Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000; 289: 2126-2128.
52. Mani A, Radhakrishnan J, Wang H, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 2007; 315: 1278-1282. (Pubitemid 46364265)